Results 41 to 50 of about 21,139,354 (341)

Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study

open access: yesClinical Psychology in Europe, 2021
[Background] As estimated by the World Health Organization, depressive disorders will be the leading contributor to the Global Burden of Disease by 2030.
Laura Ulbrich, Christoph Kröger
doaj   +1 more source

Quantifying life: Understanding the history of Quality-Adjusted Life-Years (QALYs)

open access: yesSocial Science & Medicine (1967), 2018
Quality-Adjusted Life-Years (QALYs) are central to healthcare decision-making in Britain and abroad, yet their history is poorly understood. In this paper, we argue that a more in-depth and political history of the QALY is needed to allow a critical ...
E. MacKillop, S. Sheard
semanticscholar   +1 more source

Results of deterministic sensitivity analyses for incremental costs and quality-adjusted life years (QALYs).

open access: yes, 2020
Results of deterministic sensitivity analyses for incremental costs and quality-adjusted life years (QALYs).
Benjamin Birkner (8212203)   +2 more
core   +1 more source

Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with commonly used screening measures (in 2019 $).

open access: yes, 2023
Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with commonly used screening measures (in 2019 $).
Christian Krauth (3144804)   +5 more
core   +1 more source

Results of alternative strategies: costs, life expectancy, quality-adjusted life years (QALYs) gained.

open access: yes, 2016
Results of alternative strategies: costs, life expectancy, quality-adjusted life years (QALYs) gained.
Pei Liu (93392)   +3 more
core   +1 more source

Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with newer screening measures (in 2019 $).

open access: yes, 2023
Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with newer screening measures (in 2019 $).
Christian Krauth (3144804)   +5 more
core   +1 more source

The use of Quality-Adjusted Life Years in cost-effectiveness analyses in palliative care: Mapping the debate through an integrative review

open access: yesPalliative Medicine, 2017
Background: In cost-effectiveness analyses in healthcare, Quality-Adjusted Life Years are often used as outcome measure of effectiveness. However, there is an ongoing debate concerning the appropriateness of its use for decision-making in palliative care.
Anne B. Wichmann   +6 more
semanticscholar   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

Incremental decreases in quality-adjusted life years (QALY) associated with higher levels of depressive symptoms for U.S. Adults aged 65 years and older

open access: yesHealth and Quality of Life Outcomes, 2017
BackgroundQuality-adjusted life years (QALY) is a single value index that quantifies the overall burden of disease. It reflects all aspects of heath, including nonfatal illness and mortality outcomes by weighting life-years lived with health-related ...
Hao-Miao Jia, E. Lubetkin
semanticscholar   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy